Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma PURPOSE: Patient response to hematopoietic progenitor-cell mobilizing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback